Germline BRCA Pathogenic Variants in Patients with Ovarian Cancer and Post-Poly (Adp-Ribose) Polymerase Inhibitor Myeloid Neoplasms
ESMO OPEN（2024）
Key words
advanced high-grade ovarian carcinoma,germline BRCA pathogenic variant,myelodysplastic neoplasms,PARP inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined